Standard of care off-therapy surveillance at our institution includes serial serum AFP monitoring along with risk-adapted radiographic imaging, the latter of which is controversial and not mandated on cooperative group trials of hepatoblastoma, noting that relapse with a normal AFP is uncommon. The gene discussed is AFP; the disease is hepatoblastoma.